ENJANLY

Gilead Sciences Ireland UC

Trademark Registered: 2019-07-16
Trademark Application Details
Trademark Logo ENJANLY
700
Live/Registered
REGISTERED
Research OneLook Acronym Finder
Serial Number86850076
Registration Number5802980
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameGretchen R. Stroud
Law Office AssignedM80
Employee NameHOWARD, PARKER WALDRIP

Timeline

2015-12-15Application Filed
2016-06-07Published for Opposition
2019-07-16Location: PUBLICATION AND ISSUE SECTION
2019-07-16Status: Live/Registered
2019-07-16Trademark Registered
2019-07-16Transaction Date

Trademark Applicants & Owners

Owner: Gilead Sciences Ireland UC
Entity StatementUnlimited Company
AddressIDA Business and Technology Park Carrigtohill, Co. IE
Legal Entity Type
Legal Entity State IE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

GRETCHEN R. STROUD
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY, CA 94404

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, oncological, hematological conditions, diseases and disorders; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia and lymphoma; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations
GS0051Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, oncological, hematological conditions, diseases and disorders; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia and lymphoma; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2015-12-181 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2015-12-212 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2016-02-013 DOCK D:Assigned to Examiner
SUSPENSION LETTER WRITTEN2016-02-024 CNSL R:Renewal
LETTER OF SUSPENSION E-MAILED2016-02-025 GNSL F:First Action
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2016-02-026 GNS3 O:Outgoing Correspondence
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2016-03-317 ERSI I:Incoming Correspondence
ASSIGNED TO LIE2016-04-188 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE2016-04-259 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2016-04-2510 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2016-04-2611 CNSA P:
LAW OFFICE PUBLICATION REVIEW COMPLETED2016-05-0312 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2016-05-1813 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2016-06-0714 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2016-06-0715 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2016-08-0216 NOAM E:E-Mail
TEAS EXTENSION RECEIVED2016-11-2917 EEXT I:Incoming Correspondence
EXTENSION 1 FILED2016-11-2918 EXT1 S:
EXTENSION 1 GRANTED2016-11-2919 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-12-0120 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2017-05-2421 EEXT I:Incoming Correspondence
EXTENSION 2 FILED2017-05-2422 EXT2 S:
EXTENSION 2 GRANTED2017-05-2423 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-05-2624 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2017-11-3025 EEXT I:Incoming Correspondence
EXTENSION 3 FILED2017-11-3026 EXT3 S:
EXTENSION 3 GRANTED2017-11-3027 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-12-0228 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2018-06-0529 EEXT I:Incoming Correspondence
EXTENSION 4 FILED2018-06-0530 EXT4 S:
EXTENSION 4 GRANTED2018-06-0531 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-06-0732 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2018-12-0333 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2018-12-1134 AITU A:Allowance for Publication
EXTENSION 5 FILED2018-12-0335 EXT5 S:
EXTENSION 5 GRANTED2018-12-1136 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-12-1237 EXRA E:E-Mail
TEAS DELETE 1(B) BASIS RECEIVED2019-05-3038 D1BR I:Incoming Correspondence
NOTICE OF ALLOWANCE CANCELLED2019-05-3039 IUCN S:
1(B) BASIS DELETED; PROCEED TO REGISTRATION2019-06-0740 DP1B I:Incoming Correspondence
REGISTERED-PRINCIPAL REGISTER2019-07-1641 R.PR A:Allowance for Publication
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2022-06-2942 ASGN I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed